Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Canopy Growth Corporation
CGC
$1.02
Name : Canopy Growth Corporation
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $458,062,112.00
EPSttm : -1.33
finviz dynamic chart for CGC
Canopy Growth Corporation
$1.02
0.00%
$0.00000000000000
CGC — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

5.43

Margin Of Safety %

Put/Call OI Ratio

0.18

EPS Next Q Diff

0.02

EPS Last/This Y

EPS This/Next Y

0.2

Price

1.02

Target Price

1.74

Analyst Recom

2.43

Performance Q

-3.77

Upside

-4,526.5%

Beta

0.79

Ticker: CGC



20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11CGC1.1350.180.61332619
2026-05-12CGC1.090.190.29337638
2026-05-13CGC1.0950.190.30337916
2026-05-14CGC1.080.190.54338990
2026-05-15CGC1.0350.190.47340277
2026-05-18CGC0.98420.190.26319331
2026-05-19CGC0.98780.190.12322831
2026-05-20CGC1.040.190.11327754
2026-05-21CGC1.0850.190.14328674
2026-05-22CGC1.0450.190.39331979
2026-05-26CGC1.0450.190.25320649
2026-05-27CGC1.070.190.14332373
2026-05-28CGC1.1250.190.20334022
2026-05-29CGC1.0850.190.66339337
2026-06-02CGC1.0650.190.10324513
2026-06-03CGC1.030.190.51325859
2026-06-04CGC1.0450.190.48326872
2026-06-05CGC1.0450.192.01328276
2026-06-08CGC1.0250.180.34319981
2026-06-09CGC1.0250.180.06322909
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1



21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11CGC1.13- - -0.46
2026-05-12CGC1.11- - -0.46
2026-05-13CGC1.10- - -0.46
2026-05-14CGC1.08- - -0.46
2026-05-15CGC1.03- - -0.46
2026-05-18CGC0.98- - -0.46
2026-05-19CGC0.99- - -0.46
2026-05-20CGC1.03- - -0.46
2026-05-21CGC1.09- - -0.46
2026-05-22CGC1.05- - -0.46
2026-05-26CGC1.04- - -0.46
2026-05-27CGC1.08- - -0.46
2026-05-28CGC1.12- - -0.46
2026-05-29CGC1.08- - -0.46
2026-06-01CGC1.09- - -0.46
2026-06-02CGC1.07- - -0.46
2026-06-03CGC1.03- - -0.46
2026-06-04CGC1.05- - -0.46
2026-06-05CGC1.03- - -0.46
2026-06-08CGC1.02- - -0.46
2026-06-09CGC1.02- - -0.46
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11CGC-3.931.976.34
2026-05-12CGC-3.931.976.02
2026-05-13CGC-3.931.976.02
2026-05-14CGC-3.931.976.02
2026-05-15CGC-3.931.976.02
2026-05-18CGC-3.93-0.556.02
2026-05-19CGC-3.93-0.556.02
2026-05-20CGC-3.93-0.556.02
2026-05-21CGC-3.93-0.556.02
2026-05-22CGC-3.93-0.556.02
2026-05-26CGC-3.93-3.536.02
2026-05-27CGC-3.93-3.536.02
2026-05-28CGC-3.93-3.535.43
2026-05-29CGC-3.93-3.535.43
2026-06-02CGC-3.93-3.625.43
2026-06-03CGC-3.93-3.625.43
2026-06-04CGC-3.93-3.625.43
2026-06-05CGC-3.93-3.625.43
2026-06-08CGC-3.93-3.595.43
2026-06-09CGC-3.93-3.595.43
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS​

-0.1

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

-0.08

Insider Transactions

-3.93

Institutional Transactions

-3.59

Beta

0.79

Average Sales Estimate Current Quarter

75

Average Sales Estimate Next Quarter

87

Fair Value

Quality Score

36

Growth Score

33

Sentiment Score

5

Actual DrawDown %

99.6

Max Drawdown 5-Year %

-99.7

Target Price

1.74

P/E

Forward P/E

PEG

P/S

2.18

P/B

0.68

P/Free Cash Flow

EPS

-1.29

Average EPS Est. Cur. Y​

-0.46

EPS Next Y. (Est.)

-0.26

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-115.39

Relative Volume

0.79

Return on Equity vs Sector %

-70.6

Return on Equity vs Industry %

-51.1

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.1

EBIT Estimation

◆ CGC Healthcare
$1.02
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
4/20
Pullback
19/25
Volume
9/15
Valuation
12/20
TP/AR
1/10
Options
8/10
RSI
42.9
Range 1M
36.3%
Sup Dist
1%
🚀
Momentum Growth
Ride accelerating trends
N/A
29 /100
WEAK
Momentum
1/25
Growth
20/30
Estimates
0/20
Inst/Vol
0/15
Options
8/10
EPS Yr
91.7%
EPS NY
47.8%
52W%
12.1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +70.6% upside
Quality
3/30
Valuation
14/30
Growth
15/25
Stability
5/10
LT Trend
1/5
Upside
+70.6%
Quality
36
Click a card to see score breakdown Full Analysis →
Canopy Growth Corporation
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 960
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
CGC

Latest News

—
Caricamento notizie per CGC…
stock quote shares CGC – Canopy Growth Corporation Stock Price stock today
news today CGC – Canopy Growth Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch CGC – Canopy Growth Corporation yahoo finance google finance
stock history CGC – Canopy Growth Corporation invest stock market
stock prices CGC premarket after hours
ticker CGC fair value insiders trading